ApiJect Announces Proof-of-Concept in Blow-Fill-Seal at Orlando Technology Development Center – Opportunity to “Test Drive” ApiJect Technology –
ApiJect Bolsters Global Health Team with Esteemed Anthropologist and Leading Expert on Vaccine Hesitancy, Dr. Heidi Larson, as Senior Advisor
Single-Dose Prefilled ApiJect Injector is Finalist in CPHI Pharma Awards 2023
ApiJect Announces Appointment of Key Pharmaceutical and Device Professionals
ApiLabs, R&D sister company to ApiJect, launches its Field Research Network
ApiJect Systems Announces Investment by Royalty Pharma and Jefferies
ApiJect Announces the Opening of the ApiJect Technology Development Center
ApiJect Systems Announces Russell “Bo” Kowalczyk Joins Company
ApiJect Announces Edward Kelley, PhD, as Chief Global Health Officer
ApiJect Announces Molly Weaver, PhD, as New Chief Technology Officer
Fareva and ApiJect Sign a Licensing Agreement
ApiJect Chief Global Health Officer Ed Kelley to Participate in INTERPHEX Live
ApiJect Issues Statement on NBC Digital News Story
ApiJect Awarded HHS-DoD Contract of $138MM
